The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-Fluorophenyl)-1,2-dihydro-2-imino-6-(4,9-dimethoxy-7-methyl-5-oxo-5H-furo[3,2-g]chromen-6-yl)pyridine-3-carbonitrile ID: ALA4083494
PubChem CID: 137646755
Max Phase: Preclinical
Molecular Formula: C26H18FN3O5
Molecular Weight: 471.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1c2occc2c(OC)c2c(=O)c(-c3cc(-c4ccc(F)cc4)c(C#N)c(=N)[nH]3)c(C)oc12
Standard InChI: InChI=1S/C26H18FN3O5/c1-12-19(18-10-16(17(11-28)26(29)30-18)13-4-6-14(27)7-5-13)21(31)20-22(32-2)15-8-9-34-23(15)25(33-3)24(20)35-12/h4-10H,1-3H3,(H2,29,30)
Standard InChI Key: NLHYRLRQFAKAFM-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
18.0943 -15.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0958 -14.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3853 -13.8195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6650 -14.2310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6660 -15.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3765 -15.4698 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8136 -13.8303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5266 -13.4201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8035 -15.4775 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9488 -16.2887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9488 -15.4621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2317 -15.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5177 -15.4621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8048 -15.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0854 -15.4621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0854 -16.2887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8048 -16.6990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5177 -16.2887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2317 -16.6990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3009 -16.5422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3009 -15.2119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8174 -15.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2317 -14.2252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6660 -16.6990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8048 -14.2252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0854 -13.8087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3843 -12.9987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1015 -12.5885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1052 -11.7635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3947 -11.3456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6775 -11.7558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6738 -12.5807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3975 -10.5193 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.8063 -17.5240 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0927 -17.9378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 3 0
2 7 1 0
1 9 2 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
18 19 1 0
10 19 1 0
21 22 2 0
20 22 1 0
15 21 1 0
16 20 1 0
12 23 2 0
10 24 1 0
25 26 1 0
14 25 1 0
5 11 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
27 32 2 0
30 33 1 0
3 27 1 0
17 34 1 0
34 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 471.44Molecular Weight (Monoisotopic): 471.1230AlogP: 5.02#Rotatable Bonds: 4Polar Surface Area: 125.24Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.55CX Basic pKa: 8.38CX LogP: 2.11CX LogD: 1.63Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: 0.13
References 1. Amin KM, Syam YM, Anwar MM, Ali HI, Abdel-Ghani TM, Serry AM.. (2017) Synthesis and molecular docking studies of new furochromone derivatives as p38α MAPK inhibitors targeting human breast cancer MCF-7 cells., 25 (8): [PMID:28291685 ] [10.1016/j.bmc.2017.02.065 ]